Companion Diagnostics Market Size- KBV Research

The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.


A companion diagnostics test is done to understand which patient can gain benefits from a specific drug or decide upon the kind of dosage that should be prescribed. All of this, on the basis of a patients clinical diagnosis, which offers required evidence for the successful and harmless utilization of an equivalent biological or drug product to treat the medical issue. These can also be referred to as medical instruments that help doctors in electing which dosage or treatment is sufficient for patients and suits to their necessity.


The growth of research and development activities in the genetic sciences and biomarkers leads to new drug development mechanisms, dominated by companion diagnostics in the personalized medicine phase. Moreover, the development and usage of companion diagnostics have considerably improved the knowledge of the molecular causes of illnesses, the identification of many biomarkers and the development of targeted treatment.


Full Report: https://www.kbvresearch.com/companion-diagnostics-market/

The Wall

No comments
You need to sign in to comment